Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

SLC2A9 influences uric acid concentrations with pronounced sex-specific effects

Abstract

Serum uric acid concentrations are correlated with gout and clinical entities such as cardiovascular disease and diabetes. In the genome-wide association study KORA (Kooperative Gesundheitsforschung in der Region Augsburg) F3 500K (n = 1,644), the most significant SNPs associated with uric acid concentrations mapped within introns 4 and 6 of SLC2A9, a gene encoding a putative hexose transporter (effects: −0.23 to −0.36 mg/dl per copy of the minor allele). We replicated these findings in three independent samples from Germany (KORA S4 and SHIP (Study of Health in Pomerania)) and Austria (SAPHIR; Salzburg Atherosclerosis Prevention Program in Subjects at High Individual Risk), with P values ranging from 1.2 × 10−8 to 1.0 × 10−32. Analysis of whole blood RNA expression profiles from a KORA F3 500K subgroup (n = 117) showed a significant association between the SLC2A9 isoform 2 and urate concentrations. The SLC2A9 genotypes also showed significant association with self-reported gout. The proportion of the variance of serum uric acid concentrations explained by genotypes was about 1.2% in men and 6% in women, and the percentage accounted for by expression levels was 3.5% in men and 15% in women.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Summary of genome-wide association and replication results.
Figure 2: Transcription analysis of SLC2A9 and association with serum uric acid concentrations.

Similar content being viewed by others

References

  1. Wilk, J.B. et al. Segregation analysis of serum uric acid in the NHLBI Family Heart Study. Hum. Genet. 106, 355–359 (2000).

    Article  CAS  PubMed  Google Scholar 

  2. Yang, Q. et al. Genome-wide search for genes affecting serum uric acid levels: the Framingham Heart Study. Metabolism 54, 1435–1441 (2005).

    Article  CAS  PubMed  Google Scholar 

  3. Cheng, L.S. et al. Genomewide scan for gout in Taiwanese aborigines reveals linkage to chromosome 4q25. Am. J. Hum. Genet. 75, 498–503 (2004).

    Article  CAS  PubMed  Google Scholar 

  4. Fang, J. & Alderman, M.H. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971–1992. National Health and Nutrition Examination Survey. J. Am. Med. Assoc. 283, 2404–2410 (2000).

    Article  CAS  Google Scholar 

  5. Stranger, B.E. et al. Population genomics of human gene expression. Nat. Genet. 39, 1217–1224 (2007).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Li, S. et al. The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genet. 3, e194 (2007).

    Article  PubMed  PubMed Central  Google Scholar 

  7. Wallace, C. et al. Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am. J. Hum. Genet. 82, 139–149 (2008).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Graessler, J. et al. Association of the human urate transporter 1 with reduced renal uric acid excretion and hyperuricemia in a German Caucasian population. Arthritis Rheum. 54, 292–300 (2006).

    Article  CAS  PubMed  Google Scholar 

  9. Shima, Y., Teruya, K. & Ohta, H. Association between intronic SNP in urate-anion exchanger gene, SLC22A12, and serum uric acid levels in Japanese. Life Sci. 79, 2234–2237 (2006).

    Article  CAS  PubMed  Google Scholar 

  10. Joost, H.G. & Thorens, B. The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members. Mol. Membr. Biol. 18, 247–256 (2001).

    Article  CAS  PubMed  Google Scholar 

  11. Burant, C.F., Takeda, J., Brot-Laroche, E., Bell, G.I. & Davidson, N.O. Fructose transporter in human spermatozoa and small intestine is GLUT5. J. Biol. Chem. 267, 14523–14526 (1992).

    CAS  PubMed  Google Scholar 

  12. Scheepers, A. et al. Characterization of the human SLC2A11 (GLUT11) gene: alternative promoter usage, function, expression, and subcellular distribution of three isoforms, and lack of mouse orthologue. Mol. Membr. Biol. 22, 339–351 (2005).

    Article  CAS  PubMed  Google Scholar 

  13. Stirpe, F. et al. Fructose-induced hyperuricaemia. Lancet 2, 1310–1311 (1970).

    Article  CAS  PubMed  Google Scholar 

  14. Hallfrisch, J. Metabolic effects of dietary fructose. FASEB J. 4, 2652–2660 (1990).

    Article  CAS  PubMed  Google Scholar 

  15. Augustin, R. et al. Identification and characterization of human glucose transporter-like protein-9 (GLUT9): alternative splicing alters trafficking. J. Biol. Chem. 279, 16229–16236 (2004).

    Article  CAS  PubMed  Google Scholar 

  16. Richardson, S. et al. Molecular characterization and partial cDNA cloning of facilitative glucose transporters expressed in human articular chondrocytes; stimulation of 2-deoxyglucose uptake by IGF-I and elevated MMP-2 secretion by glucose deprivation. Osteoarthritis Cartilage 11, 92–101 (2003).

    Article  CAS  PubMed  Google Scholar 

  17. Keembiyehetty, C. et al. Mouse glucose transporter 9 splice variants are expressed in adult liver and kidney and are up-regulated in diabetes. Mol. Endocrinol. 20, 686–697 (2006).

    Article  CAS  PubMed  Google Scholar 

  18. Wichmann, H.E., Gieger, C. & Illig, T. KORA-gen–resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen 67 Suppl. 1, S26–S30 (2005).

    Article  PubMed  Google Scholar 

  19. Heid, I.M. et al. Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians. Diabetes 55, 375–384 (2006).

    Article  CAS  PubMed  Google Scholar 

  20. John, U. et al. Study of Health In Pomerania (SHIP): a health examination survey in an east German region: objectives and design. Soz. Praventivmed. 46, 186–194 (2001).

    Article  CAS  PubMed  Google Scholar 

  21. Roddy, E., Zhang, W. & Doherty, M. The changing epidemiology of gout. Nat. Clin. Pract. Rheumatol. 3, 443–449 (2007).

    Article  PubMed  Google Scholar 

  22. Lake, S.L. et al. Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum. Hered. 55, 56–65 (2003).

    Article  CAS  PubMed  Google Scholar 

  23. Yang, Y.H. et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 30, e15 (2002).

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The MONICA/KORA Augsburg studies were financed by the Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany and supported by grants from the German Federal Ministry of Education and Research (BMBF). Part of this work was financed by the German National Genome Research Network (NGFN). Our research was supported within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ. SHIP is part of the Community Medicine Research net (CMR) of the University of Greifswald, Germany, which is funded by the Federal Ministry of Education and Research, the Ministry of Cultural Affairs as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania. The SHIP genotyping was supported by grant 03IP612 (InnoProfile) of the German Federal Ministry for Education and Research (BMBF). Part of the work on SAPHIR was supported by the 'Genomics of Lipid-associated Disorders – GOLD' of the Austrian Genome Research Programme (GEN-AU). We gratefully acknowledge the contribution of P. Lichtner, G. Eckstein, T. Strom and K. Heim and all other members of the Helmholtz Zentrum München genotyping staff in generating and analyzing the SNP and RNA dataset, as well as the contribution of A. Gehringer and M. Haak from the Division of Genetic Epidemiology, Innsbruck Medical University. We thank all members of field staffs who were involved in the planning and conduct of the MONICA/KORA Augsburg studies, the SHIP study and the SAPHIR study. Finally, we express our appreciation to all study participants.

Author information

Authors and Affiliations

Authors

Contributions

Study design and biobanking KORA F3 500K: H.-E.W., T.M., C.G., T.I., C.M., A.P. and G.F.; study design and biobanking replication studies: H.V. (SHIP), B.P. and F.K. (SAPHIR), A.D. and H.-E.W. (KORA); statistical analysis: C.G. and A.D.; Affymetrix genotyping: T.M. and T.I.; genotyping in the replication studies: F.K., S.C., D.R., K.H., N.K. and H.G.; sequencing and gene expression analysis: T.M., D.M., H.P. and A.P.; phenotype assessment: H.V., B.P., A.D., C.M. and H.-E.W.; bioinformatical analysis: S.C., H.G.; manuscript writing: C.M., A.D, C.G., T.M., H.G., S.C. and F.K.

Corresponding author

Correspondence to Christa Meisinger.

Supplementary information

Supplementary Text and Figures

Supplementary Methods, Supplementary Tables 1–7, Supplementary Figure 1 (PDF 547 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Döring, A., Gieger, C., Mehta, D. et al. SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat Genet 40, 430–436 (2008). https://doi.org/10.1038/ng.107

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng.107

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing